4
Changes in Ownership
RESMED INC Filed Acc 0001127602-23-026027
Chief Executive Officer sold 5,675 shares at $140.70 ($798,464)
- Chief Executive Officer acquired 5,675 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Farrell Michael J. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,675 | $57.76 | $327,788 | 455,035 | D |
| 2023-10-16 | Sale : show line 2 in the form 10b5-1 | −5,675 | $140.70 | $798,464 | 449,360 | D |
| Open-market sales · 5,675 sh · avg $140.70 · $798,464 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-16 | Exercise or conversion : show line 3 in the form 10b5-1 ResMed Common Stock Options | −5,675 | 9,140 | D |
Loading xslF345X05/form4.xml…